Next 10 |
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team will be hosting one-on-one meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism, on July 9, ...
2024-06-17 09:36:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks sometimes get a bad rep due to their inherent risk. They are cheap but are considered highly volatile and have a low chance of providing substantial profit. However, there are ...
Data from 13 participants presented at the American Transplant Congress continue to support safety and tolerability profile of tegoprubart Overall mean eGFR of all reported time points after day 30 post-transplant of 70.5 mL/min/1.73m² Mean eGFR measured above 60 mL/min/1.73m...
2024-05-24 16:20:20 ET More on Eledon Pharmaceuticals World’s first pig-to-human kidney transplant performed in U.S Seeking Alpha’s Quant Rating on Eledon Pharmaceuticals Historical earnings data for Eledon Pharmaceuticals Financial information ...
2024-05-13 08:19:44 ET More on pre-market losers & stocks. AEye, Inc. (LIDR) Q4 2023 Earnings Call Transcript World’s first pig-to-human kidney transplant performed in U.S Seeking Alpha’s Quant Rating on Eledon Pharmaceuticals Historical ear...
2024-05-09 13:54:59 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eledon Pharma (NASDAQ: ELDN ) just reported results for the first quarter of 2024. Eledon Pharma reported earnings per share of -34 cents. This was above the analyst estim...
2024-05-09 08:04:16 ET More on Eledon Pharmaceuticals World’s first pig-to-human kidney transplant performed in U.S Seeking Alpha’s Quant Rating on Eledon Pharmaceuticals Historical earnings data for Eledon Pharmaceuticals Financial information ...
Completed oversubscribed $50 million private placement First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes Reported updated data from ongoing Phas...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company will participate in the American Transplant Congress (ATC) taking place in Philadelphia, PA from June 1-5, 2024. The Company will present a p...
News, Short Squeeze, Breakout and More Instantly...
Eledon Pharmaceuticals Inc Com Company Name:
ELDN Stock Symbol:
NASDAQ Market:
Eledon Pharmaceuticals Inc Com Website:
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team will be hosting one-on-one meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism, on July 9, ...
Data from 13 participants presented at the American Transplant Congress continue to support safety and tolerability profile of tegoprubart Overall mean eGFR of all reported time points after day 30 post-transplant of 70.5 mL/min/1.73m² Mean eGFR measured above 60 mL/min/1.73m...